Corporate Profile

  The new era for "regenerative medicine" is upon us, holding great promise to change the basic concept of medicine. The totally new therapy enables the regeneration of lost or functionally impaired tissues and organs, utilizing their own cells and the body's inherent regenerative ability. Based upon a new concept, "cell-sheet engineering," CellSeed is pursuing the regenerative possibilities of every tissue and organ through our research and development. Along with our innovative medical collaborators, we are confirming the proof of the concept and making great efforts to launch the advanced medical products as entirely new therapies. By building various types of cell sheets using patients' specific cultured cells, many highly effective regenerative tissues have restored or replaced damaged ones. Especially for the cornea regeneration using our cell-sheet technology, we are substantially progressing towards commercialization. We are proud to provide a literal light of hope for those suffering from corneal disease in the world and to make this contribution to worldwide medical treatment.

  Moving aggressively to cover a wide range of regenerative medicine, such as 'cardiac patch' for myocardial infarction, periodontal disease treatment, cartilage regeneration as well as treatment for esophageal cancer, we continue our effort to put this highly innovative technology into practice while reducing costs. With safety and quality as our foremost priorities, we explore new possibilities in regenerative medicine. We believe that our mission, "improving patients' quality of life," will lead to our significant contributions to the world, building a robust bridge to a brighter future.